US Stock MarketDetailed Quotes

MNOV MediciNova

Watchlist
  • 1.700
  • -0.040-2.30%
Trading Feb 26 15:05 ET
83.38MMarket Cap-7.39P/E (TTM)

MediciNova Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-43.22%-10.64M
-287.07%-1.93M
-48.16%-2.03M
-17.96%-2.81M
-21.74%-3.87M
42.45%-7.43M
87.55%-499.06K
49.58%-1.37M
2.97%-2.38M
14.78%-3.18M
Net income from continuing operations
-28.91%-11.05M
-36.69%-2.81M
-294.43%-2.85M
8.48%-2.63M
5.59%-2.75M
39.08%-8.57M
31.40%-2.06M
80.20%-723.11K
28.72%-2.87M
13.85%-2.92M
Operating gains losses
-100.04%-198
-100.00%1
----
----
----
266.91%449.38K
--346.49K
--371
--0
--102.51K
Depreciation and amortization
3.85%21.08K
-5.74%5.18K
-9.17%5.18K
7.51%5.37K
30.33%5.35K
14.62%20.3K
26.81%5.49K
27.90%5.7K
11.30%5K
-7.32%4.11K
Other non cash items
214.24%173.52K
114.88%44.34K
-8.36%43.58K
-26.30%36.2K
-0.26%49.39K
-473.04%-151.89K
-236.61%-298.09K
70.60%47.56K
-12.61%49.12K
9.61%49.52K
Change In working capital
-974.71%-979.56K
-67.34%569.41K
128.95%266.7K
-496.20%-431.76K
-68.91%-1.38M
-66.48%111.99K
248.71%1.74M
-224.25%-921.22K
-91.20%108.98K
-73.35%-819.31K
-Change in prepaid assets
-270.71%-491.01K
-15.96%264.82K
23.33%191.68K
-409.15%-395.75K
-77.46%-551.75K
90.98%287.63K
57.12%315.11K
82.07%155.42K
-69.44%128.01K
43.90%-310.91K
-Change in payables and accrued expense
-1,723.59%-312.35K
-25.93%353.25K
500.17%115.25K
-98.33%507
-70.14%-781.35K
-94.15%19.24K
135.82%476.91K
-104.09%-28.8K
-96.40%30.37K
-512.43%-459.25K
-Change in other current liabilities
9.58%-176.2K
-0.36%-48.65K
15.91%-40.23K
26.10%-36.51K
-3.37%-50.81K
-33.92%-194.88K
-16.01%-48.48K
0.56%-47.84K
-91.54%-49.41K
-64.80%-49.15K
Cash from discontinued investing activities
Operating cash flow
-43.22%-10.64M
-287.07%-1.93M
-48.16%-2.03M
-17.96%-2.81M
-21.74%-3.87M
42.45%-7.43M
87.55%-499.06K
49.58%-1.37M
2.97%-2.38M
14.78%-3.18M
Investing cash flow
Cash flow from continuing investing activities
-100.00%-697
-95.45%1
107.03%193
95.20%-891
0
199.76%39.91M
100.00%22
99.97%-2.74K
-18.58K
39.93M
Net PPE purchase and sale
96.73%-697
-95.45%1
107.03%193
----
----
-325.13%-21.3K
100.44%22
---2.74K
----
----
Net investment purchase and sale
--0
--0
--0
--0
--0
199.82%39.93M
--0
--0
--0
--39.93M
Cash from discontinued investing activities
Investing cash flow
-100.00%-697
-95.45%1
107.03%193
95.20%-891
--0
199.76%39.91M
100.00%22
99.97%-2.74K
---18.58K
--39.93M
Financing cash flow
Cash flow from continuing financing activities
Cash from discontinued financing activities
Net cash flow
Beginning cash position
175.59%51M
-17.91%42.28M
-16.15%44.34M
-14.70%47.14M
175.59%51M
-74.09%18.51M
-1.90%51.51M
-18.94%52.88M
-18.37%55.26M
-74.09%18.51M
Current changes in cash
-132.77%-10.64M
-287.09%-1.93M
-47.85%-2.03M
-17.08%-2.81M
-110.53%-3.87M
161.38%32.48M
98.53%-499.04K
89.20%-1.37M
1.90%-2.4M
1,085.72%36.75M
Effect of exchange rate changes
-77.09%3.96K
222.18%10.85K
-570.83%-25.35K
-41.36%10.85K
234.58%7.61K
202.75%17.27K
-186.36%-8.88K
191.95%5.38K
232.71%18.5K
131.13%2.27K
End cash Position
-20.86%40.36M
-20.86%40.36M
-17.91%42.28M
-16.15%44.34M
-14.70%47.14M
175.59%51M
175.59%51M
-1.90%51.51M
-18.94%52.88M
-18.37%55.26M
Free cash flow
-42.83%-10.64M
-287.09%-1.93M
-47.86%-2.03M
-17.08%-2.81M
-21.74%-3.87M
42.30%-7.45M
87.56%-499.04K
49.48%-1.37M
2.21%-2.4M
14.78%-3.18M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -43.22%-10.64M-287.07%-1.93M-48.16%-2.03M-17.96%-2.81M-21.74%-3.87M42.45%-7.43M87.55%-499.06K49.58%-1.37M2.97%-2.38M14.78%-3.18M
Net income from continuing operations -28.91%-11.05M-36.69%-2.81M-294.43%-2.85M8.48%-2.63M5.59%-2.75M39.08%-8.57M31.40%-2.06M80.20%-723.11K28.72%-2.87M13.85%-2.92M
Operating gains losses -100.04%-198-100.00%1------------266.91%449.38K--346.49K--371--0--102.51K
Depreciation and amortization 3.85%21.08K-5.74%5.18K-9.17%5.18K7.51%5.37K30.33%5.35K14.62%20.3K26.81%5.49K27.90%5.7K11.30%5K-7.32%4.11K
Other non cash items 214.24%173.52K114.88%44.34K-8.36%43.58K-26.30%36.2K-0.26%49.39K-473.04%-151.89K-236.61%-298.09K70.60%47.56K-12.61%49.12K9.61%49.52K
Change In working capital -974.71%-979.56K-67.34%569.41K128.95%266.7K-496.20%-431.76K-68.91%-1.38M-66.48%111.99K248.71%1.74M-224.25%-921.22K-91.20%108.98K-73.35%-819.31K
-Change in prepaid assets -270.71%-491.01K-15.96%264.82K23.33%191.68K-409.15%-395.75K-77.46%-551.75K90.98%287.63K57.12%315.11K82.07%155.42K-69.44%128.01K43.90%-310.91K
-Change in payables and accrued expense -1,723.59%-312.35K-25.93%353.25K500.17%115.25K-98.33%507-70.14%-781.35K-94.15%19.24K135.82%476.91K-104.09%-28.8K-96.40%30.37K-512.43%-459.25K
-Change in other current liabilities 9.58%-176.2K-0.36%-48.65K15.91%-40.23K26.10%-36.51K-3.37%-50.81K-33.92%-194.88K-16.01%-48.48K0.56%-47.84K-91.54%-49.41K-64.80%-49.15K
Cash from discontinued investing activities
Operating cash flow -43.22%-10.64M-287.07%-1.93M-48.16%-2.03M-17.96%-2.81M-21.74%-3.87M42.45%-7.43M87.55%-499.06K49.58%-1.37M2.97%-2.38M14.78%-3.18M
Investing cash flow
Cash flow from continuing investing activities -100.00%-697-95.45%1107.03%19395.20%-8910199.76%39.91M100.00%2299.97%-2.74K-18.58K39.93M
Net PPE purchase and sale 96.73%-697-95.45%1107.03%193---------325.13%-21.3K100.44%22---2.74K--------
Net investment purchase and sale --0--0--0--0--0199.82%39.93M--0--0--0--39.93M
Cash from discontinued investing activities
Investing cash flow -100.00%-697-95.45%1107.03%19395.20%-891--0199.76%39.91M100.00%2299.97%-2.74K---18.58K--39.93M
Financing cash flow
Cash flow from continuing financing activities
Cash from discontinued financing activities
Net cash flow
Beginning cash position 175.59%51M-17.91%42.28M-16.15%44.34M-14.70%47.14M175.59%51M-74.09%18.51M-1.90%51.51M-18.94%52.88M-18.37%55.26M-74.09%18.51M
Current changes in cash -132.77%-10.64M-287.09%-1.93M-47.85%-2.03M-17.08%-2.81M-110.53%-3.87M161.38%32.48M98.53%-499.04K89.20%-1.37M1.90%-2.4M1,085.72%36.75M
Effect of exchange rate changes -77.09%3.96K222.18%10.85K-570.83%-25.35K-41.36%10.85K234.58%7.61K202.75%17.27K-186.36%-8.88K191.95%5.38K232.71%18.5K131.13%2.27K
End cash Position -20.86%40.36M-20.86%40.36M-17.91%42.28M-16.15%44.34M-14.70%47.14M175.59%51M175.59%51M-1.90%51.51M-18.94%52.88M-18.37%55.26M
Free cash flow -42.83%-10.64M-287.09%-1.93M-47.86%-2.03M-17.08%-2.81M-21.74%-3.87M42.30%-7.45M87.56%-499.04K49.48%-1.37M2.21%-2.4M14.78%-3.18M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Trending Stocks

Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Widespread uptick! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. Chinese stocks l Show More